Our functional experiments demonstrated that B-Myb overexpression significantly induced CRC cell proliferation and cell motility accompanied by cell cycle progression, whereas B-Myb knockdown inhibits the malignant phenotypes. Here, MYBL2 is linked to colorectal carcinoma.